Edwards Lifesciences Cash and Equivalents USD Trend

Edwards Lifesciences Corporation -- USA Stock  

USD 135.64  1.97  1.47%

This module enables investors to look at Edwards Lifesciences various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Consolidated Income of 560.2 M, Cost of Revenue of 744.5 M or Earning Before Interest and Taxes EBIT of 735.1 M, but also many exotic indicators such as Interest Coverage of 83.0439, Long Term Debt to Equity of 0.2914 or Calculated Tax Rate of 22.793. This module is a perfect complement to use when analyzing Edwards Lifesciences Valuation or Volatility. It can also complement various Edwards Lifesciences Technical models. Additionally see analysis of Edwards Lifesciences Correlation with competitors.
Showing smoothed Cash and Equivalents USD of Edwards Lifesciences Corporation with missing and latest data points interpolated. Cash and Equivalents in USD, converted by [FXUSD].
Cash and Equivalents USD  10 Years Trend  
Increasing
Slightly volatile
 Cash and Equivalents USD 
      Timeline 

Edwards Lifesciences Cash and Equivalents USD Over Time

2016-12-31  930,100,000 
2017-12-31  930,100,000 
2018-12-31  867,631,579 

Other Fundumenentals

 

Regression Statistics

Arithmetic Mean  472,379,352
Geometric Mean  357,254,979
Coefficient Of Variation  66.02
Mean Deviation  267,405,357
Median  396,100,000
Standard Deviation  311,862,008
Range  882,400,000
R Value  0.93
R Squared  0.87
Significance  0.00000282
Slope  74,858,184

Currently Trending

UL   
 NYQ 
Purchased over 50 shares of
few hours ago ago
Traded for 52.09
GOOG   
 NMS 
Purchased few shares of
few hours ago ago
Traded for 1106.63
F   
 NYQ 
Purchased over 200 shares of
few hours ago ago
Traded for 10.63